학술논문
MRI and 18 FET-PET predict survival benefit from bevacizumab plus radiotherapy in patients with isocitrate dehydrogenase wild-type glioblastoma: results from the randomized ARTE trial
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 January 2021, 27(1):179-188)
Subject
Language
English
ISSN
15573265
10780432
10780432